{"id":"https://openalex.org/W2013966013","doi":"https://doi.org/10.3389/fphar.2015.00057","title":"Progress in antiandrogen design targeting hormone binding pocket to circumvent mutation based resistance","display_name":"Progress in antiandrogen design targeting hormone binding pocket to circumvent mutation based resistance","publication_year":2015,"publication_date":"2015-03-24","ids":{"openalex":"https://openalex.org/W2013966013","doi":"https://doi.org/10.3389/fphar.2015.00057","mag":"2013966013","pmid":"https://pubmed.ncbi.nlm.nih.gov/25852559","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4371693"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2015.00057","doi":"https://doi.org/10.3389/fphar.2015.00057","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2015.00057","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2015.00057/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fphar.2015.00057/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049168000","display_name":"Xiaohong Tian","orcid":"https://orcid.org/0000-0003-3580-7501","observed_orcids":["https://orcid.org/0000-0003-3580-7501"]},"institutions":[{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405267356","display_name":"Lady Davis Institute for Medical Research","ror":"https://ror.org/02c1np254","country_code":"CA","type":"education","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405267356","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Xiaohong Tian","raw_affiliation_strings":["Lady Davis Institute, Jewish General Hospital, Mcgill University Montreal, QC, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lady Davis Institute, Jewish General Hospital, Mcgill University Montreal, QC, Canada","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405267356","https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113874167","display_name":"Yang He","orcid":"https://orcid.org/0000-0002-1066-3575","observed_orcids":["https://orcid.org/0000-0002-1066-3575","https://orcid.org/0000-0003-0857-9478"]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yang He","raw_affiliation_strings":["Immunology, Institute of Medicinal Biotechnology Chinese Academy of Medical Science, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology, Institute of Medicinal Biotechnology Chinese Academy of Medical Science, Beijing, China","institution_ids":["https://openalex.org/I200296433"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056603093","display_name":"Jinming Zhou","orcid":"https://orcid.org/0000-0003-1610-5061","observed_orcids":["https://orcid.org/0000-0003-1610-5061"]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jinming Zhou","raw_affiliation_strings":["Immunology, Institute of Medicinal Biotechnology Chinese Academy of Medical Science, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology, Institute of Medicinal Biotechnology Chinese Academy of Medical Science, Beijing, China","institution_ids":["https://openalex.org/I200296433"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5056603093"],"corresponding_institution_ids":["https://openalex.org/I200296433"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.5252,"has_fulltext":true,"cited_by_count":33,"citation_normalized_percentile":{"value":0.46590909,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"6","issue":null,"first_page":"57","last_page":"57"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/androgen-receptor-antagonists","display_name":"androgen receptor antagonists","score":0.7730000019073486},{"id":"https://openalex.org/keywords/androgen-receptor","display_name":"androgen receptor","score":0.9980000257492065},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.8619999885559082},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.9480000138282776},{"id":"https://openalex.org/keywords/ar-mutations","display_name":"AR mutations","score":0.6740000247955322},{"id":"https://openalex.org/keywords/enzalutamide","display_name":"enzalutamide","score":0.8399999737739563},{"id":"https://openalex.org/keywords/bicalutamide","display_name":"bicalutamide","score":0.9549999833106995},{"id":"https://openalex.org/keywords/flutamide","display_name":"flutamide","score":0.9919999837875366},{"id":"https://openalex.org/keywords/rational-drug-design","display_name":"rational drug design","score":0.6949999928474426}],"concepts":[{"id":"https://openalex.org/C2910016293","wikidata":"https://www.wikidata.org/wiki/Q574820","display_name":"Antiandrogens","level":5,"score":0.9709911942481995},{"id":"https://openalex.org/C2780962315","wikidata":"https://www.wikidata.org/wiki/Q1988832","display_name":"Bicalutamide","level":5,"score":0.8834548592567444},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.882800817489624},{"id":"https://openalex.org/C2778313021","wikidata":"https://www.wikidata.org/wiki/Q418669","display_name":"Flutamide","level":5,"score":0.7828747034072876},{"id":"https://openalex.org/C2779322244","wikidata":"https://www.wikidata.org/wiki/Q574820","display_name":"Antiandrogen","level":4,"score":0.7291475534439087},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6323588490486145},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.5992167592048645},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5178604125976562},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47320979833602905},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.464609295129776},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3673084080219269},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3551102578639984},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3372039496898651},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.22344624996185303},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2146030068397522}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3389/fphar.2015.00057","doi":"https://doi.org/10.3389/fphar.2015.00057","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2015.00057","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2015.00057/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3352897","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4371693","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:25852559","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25852559","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4371693","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4371693/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:4f60c0b49c9e494e83b011d99ddc89f8","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/4f60c0b49c9e494e83b011d99ddc89f8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 6 (2015)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2015.00057","doi":"https://doi.org/10.3389/fphar.2015.00057","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2015.00057","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2015.00057/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320310638","display_name":"McGill University","ror":"https://ror.org/01pxwe438"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2013966013.pdf","grobid_xml":"https://content.openalex.org/works/W2013966013.grobid-xml"},"referenced_works_count":82,"referenced_works":["https://openalex.org/W63679789","https://openalex.org/W1209284060","https://openalex.org/W1493920337","https://openalex.org/W1537737183","https://openalex.org/W1795111525","https://openalex.org/W1964197275","https://openalex.org/W1964741914","https://openalex.org/W1966681846","https://openalex.org/W1968469772","https://openalex.org/W1968786809","https://openalex.org/W1972493003","https://openalex.org/W1974044349","https://openalex.org/W1976906502","https://openalex.org/W1978477477","https://openalex.org/W1981652396","https://openalex.org/W1982984638","https://openalex.org/W1984638038","https://openalex.org/W1986385964","https://openalex.org/W1988606473","https://openalex.org/W1990241243","https://openalex.org/W1999936353","https://openalex.org/W2001245006","https://openalex.org/W2001306342","https://openalex.org/W2005030355","https://openalex.org/W2005060568","https://openalex.org/W2005958584","https://openalex.org/W2006138763","https://openalex.org/W2009831081","https://openalex.org/W2010142538","https://openalex.org/W2017184248","https://openalex.org/W2023209616","https://openalex.org/W2025031463","https://openalex.org/W2025740070","https://openalex.org/W2036564302","https://openalex.org/W2050714175","https://openalex.org/W2051025382","https://openalex.org/W2052977045","https://openalex.org/W2060527003","https://openalex.org/W2063999453","https://openalex.org/W2065713171","https://openalex.org/W2070517005","https://openalex.org/W2070734804","https://openalex.org/W2074831305","https://openalex.org/W2075750372","https://openalex.org/W2080748037","https://openalex.org/W2080795487","https://openalex.org/W2084148944","https://openalex.org/W2086301534","https://openalex.org/W2087488992","https://openalex.org/W2096851248","https://openalex.org/W2100531189","https://openalex.org/W2106787323","https://openalex.org/W2110841612","https://openalex.org/W2116582477","https://openalex.org/W2118238803","https://openalex.org/W2119317569","https://openalex.org/W2121158863","https://openalex.org/W2121846636","https://openalex.org/W2128049690","https://openalex.org/W2134988422","https://openalex.org/W2136294116","https://openalex.org/W2141569270","https://openalex.org/W2151603894","https://openalex.org/W2152046394","https://openalex.org/W2155368234","https://openalex.org/W2161123101","https://openalex.org/W2165177861","https://openalex.org/W2166324735","https://openalex.org/W2167968468","https://openalex.org/W2169077388","https://openalex.org/W2171316518","https://openalex.org/W2207293016","https://openalex.org/W2312567397","https://openalex.org/W2318833604","https://openalex.org/W2318978828","https://openalex.org/W2323928671","https://openalex.org/W2324489480","https://openalex.org/W2325391880","https://openalex.org/W2329325567","https://openalex.org/W2411223014","https://openalex.org/W2416000723","https://openalex.org/W2766039556"],"related_works":["https://openalex.org/W2903289577","https://openalex.org/W2134988422","https://openalex.org/W1986385964","https://openalex.org/W3159124807","https://openalex.org/W7164851990","https://openalex.org/W1533984495","https://openalex.org/W206608110","https://openalex.org/W2952944061","https://openalex.org/W2551498408","https://openalex.org/W2239109946"],"abstract_inverted_index":{"Androgen":[0],"receptor":[1],"(AR)":[2],"plays":[3],"a":[4,96],"critical":[5],"role":[6],"in":[7],"the":[8,30,53,66,76,81,87,93,100,103],"development":[9,101],"and":[10,24,44,86],"progression":[11],"of":[12,35,52,75,80,102,106],"prostate":[13],"cancer":[14],"(PCa).":[15],"Current":[16],"clinically":[17,83],"used":[18,84],"antiandrogens":[19,47,85,107],"such":[20],"as":[21],"flutamide,":[22],"bicalutamide,":[23],"newly":[25],"approved":[26],"enzalutamide":[27],"mainly":[28],"target":[29],"hormone":[31],"binding":[32],"pocket":[33],"(HBP)":[34],"AR.":[36,54],"However,":[37],"over":[38],"time,":[39],"drug":[40,67,89],"resistance":[41,79],"invariably":[42],"develops":[43],"switches":[45],"these":[46],"from":[48],"antagonist":[49],"to":[50,91],"agonist":[51],"Accumulated":[55],"evidence":[56],"indicates":[57],"that":[58],"AR":[59],"mutation":[60,77],"is":[61],"an":[62,73],"important":[63],"cause":[64],"for":[65,99],"resistance.":[68],"This":[69],"review":[70],"will":[71],"give":[72],"overview":[74],"based":[78],"current":[82],"rational":[88],"design":[90],"overcome":[92],"resistance,":[94],"provides":[95],"promising":[97],"strategy":[98],"new":[104],"generation":[105],"targeting":[108],"HBP.":[109]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}